全文获取类型
收费全文 | 1107篇 |
免费 | 118篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 47篇 |
妇产科学 | 11篇 |
基础医学 | 138篇 |
口腔科学 | 23篇 |
临床医学 | 108篇 |
内科学 | 252篇 |
皮肤病学 | 25篇 |
神经病学 | 74篇 |
特种医学 | 128篇 |
外科学 | 55篇 |
综合类 | 36篇 |
预防医学 | 63篇 |
眼科学 | 9篇 |
药学 | 67篇 |
中国医学 | 3篇 |
肿瘤学 | 191篇 |
出版年
2024年 | 2篇 |
2023年 | 2篇 |
2022年 | 8篇 |
2021年 | 14篇 |
2020年 | 15篇 |
2019年 | 18篇 |
2018年 | 40篇 |
2017年 | 19篇 |
2016年 | 33篇 |
2015年 | 19篇 |
2014年 | 45篇 |
2013年 | 46篇 |
2012年 | 45篇 |
2011年 | 49篇 |
2010年 | 39篇 |
2009年 | 42篇 |
2008年 | 59篇 |
2007年 | 66篇 |
2006年 | 40篇 |
2005年 | 53篇 |
2004年 | 62篇 |
2003年 | 60篇 |
2002年 | 71篇 |
2001年 | 44篇 |
2000年 | 37篇 |
1999年 | 34篇 |
1998年 | 39篇 |
1997年 | 22篇 |
1996年 | 19篇 |
1995年 | 18篇 |
1994年 | 19篇 |
1993年 | 19篇 |
1992年 | 14篇 |
1991年 | 13篇 |
1990年 | 15篇 |
1989年 | 13篇 |
1988年 | 16篇 |
1987年 | 6篇 |
1986年 | 10篇 |
1985年 | 8篇 |
1984年 | 4篇 |
1983年 | 5篇 |
1982年 | 6篇 |
1981年 | 3篇 |
1980年 | 4篇 |
1979年 | 3篇 |
1978年 | 5篇 |
1977年 | 2篇 |
1975年 | 3篇 |
1974年 | 2篇 |
排序方式: 共有1233条查询结果,搜索用时 0 毫秒
1.
2.
骨巨细胞瘤的MRI诊断价值 总被引:10,自引:0,他引:10
目的探讨骨巨细胞瘤的MRI表现特点及其病理基础。资料与方法搜集经手术病理证实的12例骨巨细胞瘤患者资料,分析其MRI征象并与病理结果对照。结果T1WI上肿瘤实体表现为低、等信号,T2WI上为不均匀高信号,Gd-DTPA增强扫描呈中度到明显强化。此外,MRI还可显示肿瘤内坏死、出血、含铁血黄素沉着等。结论MRI能够提供比较全面的影像学信息,可提高对骨巨细胞瘤诊断的准确性。 相似文献
3.
J. A. Garrote A. Blanco M. Alonso E. Arranz C. Calvo 《Pediatric allergy and immunology》1991,2(4):199-204
The new diagnostic criteria of coeliac disease (CD) give more importance to serological markers. Immunoglobulin A antiendomysial antibodies (IgA-EmA) were determined in 138 sera from 79 coeliac children and the antibody levels compared to IgG and IgA antigliadin antibodies (IgG-AGA, IgA-AGA) in the sera. The assessment was also carried out in 29 children with other gastrointestinal diseases, 29 with non-gastrointestinal diseases and 35 healthy children. The IgA-EmA had a 91.4% specificity and a 88.4% sensitivity for active CD. The corresponding figures were 89.8% and 64.4% for IgA-AGA and 73.7% and 86.2% for IgG-AGA, respectively. The results of IgA-EmA determinations were concordant with the intestinal biopsy findings in 90% of cases, versus 80% for IgA-AGA and 83% for IgG-AGA. In most of the discordant cases the biopsy showed only minor changes, making the classification difficult. All patients with positive IgA2 -EmA also had positive IgA1 EmA antibodies. IgA-EmA are an excellent serological marker of CD activity in children and they are useful to decrease the number of intestinal biopsies which are needed to confirm the diagnosis in coeliac patients. 相似文献
4.
5.
Hemobilia. 总被引:1,自引:0,他引:1
D Va?ó J García-Cano J Gómez-Ruiz G Arranz 《Revista española de enfermedades digestivas》2006,98(3):216-217
6.
M I Arranz Pe?a E Saenz Lope 《Zeitschrift für klinische Chemie und klinische Biochemie》1988,26(11):791-793
A nitrogen-specific gas-chromatographic method is described for the quantitative analysis of soluphylline without the need for derivatization or evaporation of solvent, and using only 50 microliters of serum. The analysis is performed isothermally on a silicone stationary phase, 2% SP 2250 DA (Supelco). After a single neutral extraction with ethyl acetate containing the internal standard (beta-hydroxypropyl theophylline), an aliquot of the organic solvent is injected directly into the gas chromatograph. The detector sensitivity (least measurable amount) for soluphylline was 1 ng. 相似文献
7.
8.
Novel proteins with binding specificity for DNA CTG repeats and RNA CUG repeats: implications for myotonic dystrophy 总被引:7,自引:6,他引:7
While an unstable CTG triplet repeat expansion is responsible for myotonic
dystrophy, the mechanism whereby this genetic defect induces the disease
remains unknown. To detect proteins binding to CTG triplet repeats, we
performed bandshift analysis using as probes double- stranded DNA fragments
having CTG repeats [ds(CTG)6-10] and single- stranded oligonucleotides
having CTG repeats ss(CTG)8 or RNA CUG triplet repeats (CUG)8. The source
of protein was nuclear and cytoplasmic extracts of HeLa cells, fibroblasts
and myotubes. Proteins binding to the double-stranded DNA repeat
[ds(CTG)6-10], were inhibited by nonlabeled ds(CTG)6-10, but not by a
non-specific DNA fragment (USF/AD-ML). Another protein binding to ssCTG
probe and RNA CUG probe was inhibited by nonlabeled (CTG)8 and (CUG)8.
Nonlabeled oligos with different triplet repeat sequences, ss(CAG)8 or
ss(CGG)8, did not inhibit binding to the ss(CTG)8 probe. However, when
labeled as probes, the (CAG)8 and (CGG)8 bound to proteins distinct from
the CTG proteins and binding was inhibited by nonlabeled (CAG)8 or (CGG)8
respectively. The protein binding only to the RNA repeat (CUG)8 was
inhibited by nonlabeled (CUG)8 but not by nonlabeled single- or
double-stranded CTG repeats. Furthermore, the CUG-BP exhibited no binding
to an RNA oligonucleotide of triplet repeats of the same length but having
a different sequence, CGG. The CUG binding protein was localized to the
cytoplasm, whereas dsDNA binding proteins were localized to the nuclear
extract. Thus, several trinucleotide binding proteins exist and their
specificity is determined by the triplet sequence. The novel protein,
CUG-BP, is particularly interesting since it binds to triplet repeats known
to be present in myotonin protein kinase mRNA which is responsible for
myotonic dystrophy.
相似文献
9.
Ricardo Pietrobon Anand Shah Paul Kuo Matthew Harker Mariana McCready Christeen Butler Henrique Martins CT Moorman Danny O Jacobs 《BMC medical informatics and decision making》2006,6(1):32-11
Background
Although regulatory compliance in academic research is enforced by law to ensure high quality and safety to participants, its implementation is frequently hindered by cost and logistical barriers. In order to decrease these barriers, we have developed a Web-based application, Duke Surgery Research Central (DSRC), to monitor and streamline the regulatory research process. 相似文献10.
Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases 总被引:9,自引:0,他引:9
Delgado M Abad C Martinez C Juarranz MG Arranz A Gomariz RP Leceta J 《Journal of molecular medicine (Berlin, Germany)》2002,80(1):16-24
Vasoactive intestinal peptide (VIP), a neuropeptide that is produced by lymphoid as well as neural cells, exerts a wide spectrum of immunological functions, controlling the homeostasis of the immune system through different receptors expressed in various immunocompetent cells. In the last decade, VIP has been clearly identified as a potent anti-inflammatory factor, which acts by regulating the production of both anti- and pro-inflammatory mediators. In this sense, VIP has been described to prevent death by septic shock, an acute inflammatory disease with a high mortality. In addition, VIP regulates the expression of co-stimulatory molecules, this being an action that may be related to modulating the shift toward Th1 and Th2 differentiation. We have recently reported that VIP prevents the deleterious effects of an experimental model of rheumatoid arthritis, by downregulating both inflammatory and autoimmune components of the disease. Therefore, VIP has been proposed as a promising candidate alternative treatment for acute and chronic inflammatory and autoimmune diseases such as septic shock, arthritis, multiple sclerosis, Crohn disease, or autoimmune diabetes. 相似文献